Eversense XL is the world’s first long-term CGM, with exceptional accuracy and a fully insertable sensor that lasts for up to 180 days. It can help you better manage your diabetes1 by providing real-time insight into your changing glucose levels, which you can discreetly check on your compatible mobile device. People using Eversense say it helps them feel more confident about controlling their diabetes,2 and we hope it does the same for you.
Eversense XL CGM System
Eversense XL is the first and only long-term CMG that has a sensor that is changed only 2-3 times per year by a healthcare provider – no more weekly self-insertions. Eversense provides you with the Freedom you've always wanted from a CGM.
288 readings every 24 hours
Glucose readings every 5 minutes help you not only where you are, but where you’re going. Trend arrows help you manage your diabetes before going too high or too low.
Gentle, non-irritating adhesive
Eversense uses a hypoallergenic silicone-based adhesive that’s gentle on the skin.
Alerts you can see, feel and hear
Eversense XL can send you pop-up messages on your phone, sound an alarm or vibrate on your arm to alert you to highs and lows, based on your customized settings.
No Sensor Self-Insertion
Eversense XL is inserted by your healthcare provider 2-3 times per year, letting you avoid the burdensome self-insertion process every 7-14 days.
New to CGM
Learn about CGM and how Eversense XL can help you manage your diabetes.
Upgrading to Long-Term CGM?
Think all CGMs are the same? Learn why Eversense XL is the only long-term CGM.
1 Kropff, J., Choudhary, P., Neupane, S., Barnard, K., Bain, S. C., Kapitza, C., ... & DeVries, J. H. (2017). Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: a 180-day, prospective, multicenter, pivotal trial. Diabetes Care, 40(1), 63-68. 2 Christiansen, M. P., Klaff, L. J., Brazg, R., Chang, A. R., Levy, C. J., Lam, D., ... & Kelley, L. (2018). A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technology & Therapeutics. (PRECISE II).7. Glycemic Targets: Standards of Medical Care in Diabetes-2018 Diabetes Care 2018;41(Suppl. 1):S55–S64 3 Data on file.